Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
A report by the think-tank Policy Exchange has suggested lesson observations undertaken as part of an Ofsted inspection are not a valid or reliable way of assessing teacher performance and is recommending that Ofsted inspections should be focussed on data. The report also criticises the level of outsourcing by Ofsted to independent companies to undertake inspections and suggests schools should be inspected for one day every two years. In response Ofsted have highlighted a number of areas of agreement but state that given inspection of teaching is at the centre of their work, there is an expectation that lesson observations perform a key role.
Inspections must have a wider focus than data in the same way schools should be more than just exam factories. Inspections must continue to cover the full range of activities undertaken by a school which may not be reflected in data and that will include the enthusiasm and expertise of teachers and their relationship with students. That forms a key part of the education experience and will not be reflected in a spreadsheet.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up